BR112015007678A2 - vacina para cooperia - Google Patents

vacina para cooperia

Info

Publication number
BR112015007678A2
BR112015007678A2 BR112015007678A BR112015007678A BR112015007678A2 BR 112015007678 A2 BR112015007678 A2 BR 112015007678A2 BR 112015007678 A BR112015007678 A BR 112015007678A BR 112015007678 A BR112015007678 A BR 112015007678A BR 112015007678 A2 BR112015007678 A2 BR 112015007678A2
Authority
BR
Brazil
Prior art keywords
nucleotide sequences
cooperative
vaccine
relates
methods
Prior art date
Application number
BR112015007678A
Other languages
English (en)
Other versions
BR112015007678B1 (pt
Inventor
Claerebout Edwin
Borloo Jimmy
Vercruysse Jozef
Geldhof Peter
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Publication of BR112015007678A2 publication Critical patent/BR112015007678A2/pt
Publication of BR112015007678B1 publication Critical patent/BR112015007678B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

patente de invenção: "vacina para cooperia". a presente invenção refere-se a sequências de nucleotídeo codificando antígenos para cooperia, bem como a moléculas de dna recombinante contendo tais sequências de nucleotídeo e células expressando essas sequências de nucleotídeo. a invenção refere-se ainda a proteínas de cooperia, a métodos para produção das proteínas, sequências de nucleotídeos, moléculas de dna recombinante e hospedeiros. ainda, a invenção refere-se a vacinas que induzem imunidade protetora contra infecção por nematoides parasíticos tais como espécies do gênero cooperia e a métodos para preparação de tal vacina.
BR112015007678-5A 2012-10-09 2013-10-08 Sequência de ácido nucleico de dna complementar isolada, molécula de dna recombinante, vetor, célula hospedeira, uso dos anteriores, e vacina contra infecção por cooperia oncophora BR112015007678B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12187773 2012-10-09
EP12187773.2 2012-10-09
PCT/EP2013/070903 WO2014056885A1 (en) 2012-10-09 2013-10-08 Cooperia vaccine

Publications (2)

Publication Number Publication Date
BR112015007678A2 true BR112015007678A2 (pt) 2017-08-08
BR112015007678B1 BR112015007678B1 (pt) 2022-12-13

Family

ID=47018872

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015007678-5A BR112015007678B1 (pt) 2012-10-09 2013-10-08 Sequência de ácido nucleico de dna complementar isolada, molécula de dna recombinante, vetor, célula hospedeira, uso dos anteriores, e vacina contra infecção por cooperia oncophora

Country Status (7)

Country Link
US (2) US10105424B2 (pt)
EP (1) EP2906588B1 (pt)
AR (1) AR092939A1 (pt)
BR (1) BR112015007678B1 (pt)
CA (1) CA2886450C (pt)
ES (1) ES2717441T3 (pt)
WO (1) WO2014056885A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR092939A1 (es) * 2012-10-09 2015-05-06 Univ Gent Vacuna contra cooperia
AU2018324195A1 (en) 2017-09-01 2020-04-02 Venn Biosciences Corporation Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring
WO2024089248A1 (en) * 2022-10-27 2024-05-02 Universiteit Gent Recombinant activation-associated secreted protein

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084269A (en) 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
DE69101683T2 (de) 1990-07-30 1994-07-21 Akzo Nv Rekombinantes Mareks-Krankheitsvirus.
US5525508A (en) 1991-02-06 1996-06-11 Biotech Australia Pty Limited Haemonchus contortus vaccine
US6071518A (en) * 1992-05-29 2000-06-06 The Regents Of The University Of California GP900 glycoprotein and fragments for treatment and detection/diagnosis of cryptosporidium
US5961970A (en) 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
WO1998001550A2 (en) 1996-07-04 1998-01-15 Universiteit Utrecht Vaccine against gastro-intestinal nematodes
KR20090051129A (ko) 2004-04-05 2009-05-20 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
WO2009158729A2 (en) * 2008-06-27 2009-12-30 The Infectious Disease Research Institute Inc. Compounds and methods for diagnosis and treatment of chagas disease
CA2739796C (en) 2008-10-08 2018-11-06 Idexx Laboratories, Inc. Compositions and methods for detection of antibodies specific for anaplasma phagocytophilum (aph) and anaplasma platys (apl)
GB0922099D0 (en) 2009-12-18 2010-02-03 Moredun Res Inst Parasite Vaccine
AR092939A1 (es) * 2012-10-09 2015-05-06 Univ Gent Vacuna contra cooperia

Also Published As

Publication number Publication date
US20180369349A1 (en) 2018-12-27
WO2014056885A1 (en) 2014-04-17
US10946077B2 (en) 2021-03-16
US10105424B2 (en) 2018-10-23
EP2906588B1 (en) 2018-12-05
CA2886450A1 (en) 2014-04-17
ES2717441T3 (es) 2019-06-21
AR092939A1 (es) 2015-05-06
CA2886450C (en) 2021-10-26
US20150265687A1 (en) 2015-09-24
EP2906588A1 (en) 2015-08-19
BR112015007678B1 (pt) 2022-12-13

Similar Documents

Publication Publication Date Title
CO2018005229A2 (es) Vacuna de virus sincitial respiratorio
BR112013020070A8 (pt) moléculas de ácido nucleico que codificam novos antígenos de herpes, vacina compreendendo as mesmas e métodos de uso das mesmas
PE20150645A1 (es) Proteinas de fusion de interleuquina 10 y usos de las mismas
BR112014018396A8 (pt) Imunógenos para vacinação contra hiv
MX346245B (es) Proteina de fusion que comprende el mutante crm197 no toxico de toxina de difteria.
NZ630800A (en) Methods of preparing substituted nucleotide analogs
EA201291157A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
EA201692359A1 (ru) Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса
BR112015021884A2 (pt) vetores compreendendo sequências de polinucleotídeos de stuffer/agente de enchimento e métodos de uso
EA201391240A1 (ru) Слитые белки и комбинированные вакцины, содержащие белок е и пилин а haemophilus influenza
BR112014003477A2 (pt) composições imunoterapêuticas de levedura-muc1 e usos das mesmas
IN2014CN04586A (pt)
BR112015005987A2 (pt) vacina, métodos para induzir uma resposta imune contra um antígeno hbv, para proteção de um sujeito da infeção por hbv, para proteger o sujeito que foi diagnosticado com uma infecção por hbv, para induzir uma resposta imune contra um antígeno do hbv, para proteger um indivíduo da infecção pelo hbv, para proteger um indivíduo que foi diagnosticado com infecção pelo hbv, para proteger um indivíduo da infecção pelo hbv, para proteger um indivíduo que foi diagnosticado com infecção pelo hbv, para proteger um sujeito contra infecção por hbv e para proteger o sujeito que foi diagnosticado com uma infecção por hbv, molécula de ácido nucleico, e, proteína
PH12014502534B1 (en) Effective vaccination against porcine reproductive and respiratory syndrome (prrs) virus prior to weaning
MX351565B (es) Colageno 7 y metodos relacionados.
MA37749B1 (fr) Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine
BR112015024119A2 (pt) polipeptídeos tendo atividade de fosfolipase a e polinucleotídeos que os codificam
WO2014017493A9 (ja) ワクチン
BR112015000585A2 (pt) cepas mutantes de mycoplasma hyopneumoniae
MD20120127A2 (en) Recombinant Koi herpesvirus (KHV), method for its production and vaccine for the prevention of a disease caused by KHV
GB201017519D0 (en) Vaccines
MX2020012913A (es) Proteinas de consenso para el virus de la enfermedad de la fiebre aftosa (fmdv), secuencias de codificacion para estas y vacunas elaboradas a partir de estas.
BR112015007678A2 (pt) vacina para cooperia
MX2015013304A (es) Vacunas de nucleoproteina de la influenza.
PL406631A1 (pl) Antygen, szczepionka przeciwko grypie, układ do wytwarzania szczepionki, sposób wytwarzania antygenu oraz zastosowanie antygenu określonego powyżej do wytwarzania szczepionki przeciwko grypie

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/10/2013, OBSERVADAS AS CONDICOES LEGAIS